The groundbreaking therapy of tirzepatide peptide represents a major development in the management of diabetes mellitus type 2. Unlike existing therapies, tirzepatide affects two pathways – GLP-1 and GIP – https://tirzepatidepeptide283316.blog5star.com/42411611/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment